Sama Therapeutics
Elizabeth Buell is a Principal Clinical Scientist at Sama Therapeutics since July 2022, with concurrent roles as Affiliated Faculty at Emerson College and Adjunct Professor at Stephen F. Austin State University. Previous experience includes serving as a Clinical Audiologist Intern at the UT Dallas Callier Center for Communication Disorders and as a Medical Devices Intern at Fannin Innovation Studio. Elizabeth's research background includes positions as a Research Assistant at the Texas Biomedical Device Center and The University of Texas at Dallas. Educational qualifications include a Doctor of Audiology and a Doctor of Philosophy in Communication Sciences and Disorders from The University of Texas at Dallas, along with a Master of Science from the University of North Texas and a Bachelor of Arts from The University of Texas at Dallas.
This person is not in any teams
This person is not in any offices
Sama Therapeutics
1 followers
Sama Therapeutics is a precision neuropsychiatry AI/ML platform that synthesizes and validates predictive biomarkers grounded in neural, physiological, multi-omics, natural language, and behavioral phenotypes. The company's agile SaaS platform, iMAGiNE™, analyzes the transdiagnostic efficacy of pharmaceutical and neurostimulation modalities through precision clinical trials, causal inference, preclinical translation, and generative AI trained on proprietary and open-science datasets. With an extraordinarily interdisciplinary team, Sama Therapeutics is advancing "software as medical device" for a range of indications, including cognitive, affective, interoceptive, and substance use disorders. We invite partners to join our mission unlocking brain health through integrative neurotechnology and proven “transprognostic” algorithms: https://brainclinics.com/tdbrain-challenge/ Please reach out to contact@sama.ac for more information and a live demo.